Table 1 The basic characteristics of the included methodological quality (risk of bias) assessment tools
No. | Development Organization | Tool’s name | Type of study |
|---|---|---|---|
1 | The Cochrane Collaboration | Cochrane RoB tool and RoB 2.0 tool | Randomized controlled trial Diagnostic accuracy study |
2 | The Physiotherapy Evidence Database (PEDro) | PEDro scale | Randomized controlled trial |
3 | The Effective Practice and Organisation of Care (EPOC) Group | EPOC RoB tool | Randomized controlled trial Clinical controlled trials Controlled before-and-after study Interrupted time series studies |
4 | The Critical Appraisal Skills Programme (CASP) | CASP checklist | Randomized controlled trial Cohort study Case-control study Cross-sectional study Diagnostic test study Clinical prediction rule Economic evaluation Qualitative study Systematic review |
5 | The National Institutes of Health (NIH) | NIH quality assessment tool | Controlled intervention study Cohort study Cross-sectional study Case-control study Before-after (Pre-post) study with no control group Case-series (Interventional) Systematic review and meta-analysis |
6 | The Joanna Briggs Institute (JBI) | JBI critical appraisal checklist | Randomized controlled trial Non-randomized experimental study Cohort study Case-control study Cross-sectional study Prevalence data Case reports Economic evaluation Qualitative study Text and expert opinion papers Systematic reviews and research syntheses |
7 | The Scottish Intercollegiate Guidelines Network (SIGN) | SIGN methodology checklist | Randomized controlled trial Cohort study Case-control study Diagnostic study Economic evaluation Systematic reviews and meta-analyses |
8 | The Stroke Therapy Academic Industry Roundtable (STAIR) Group | CAMARADES tool | Animal study |
9 | The SYstematic Review Center for Laboratory animal Experimentation (SYRCLE) | SYRCLE’s RoB tool | Animal study |
10 | Sterne JAC et al. | ROBINS-I tool | Non-randomised interventional study |
11 | Slim K et al. | MINORS tool | Non-randomised interventional study |
12 | The Canada Institute of Health Economics (IHE) | IHE quality appraisal tool | Case-series (Interventional) |
13 | Wells GA et al. | Newcastle-Ottawa Scale (NOS) | Cohort study Case-control study |
14 | Downes MJ et al. | AXIS tool | Cross-sectional study |
15 | The Agency for Healthcare Research and Quality (AHRQ) | AHRQ methodology checklist | Cross-sectional/ Prevalence study |
16 | Crombie I | Crombie’s items | Cross-sectional study |
17 | The Good Research for Comparative Effectiveness (GRACE) Initiative | GRACE checklist | Comparative effectiveness research |
18 | Whiting PF et al. | QUADAS tool and QUADAS-2 tool | Diagnostic accuracy study |
19 | The National Institute for Clinical Excellence (NICE) | NICE methodology checklist | Economic evaluation |
20 | The Cabinet Office | The Quality Framework: Cabinet Office checklist | Qualitative study (social research) |
21 | Hayden JA et al. | QIPS tool | Prediction study (predictor finding study) |
22 | Wolff RF et al. | PROBAST | Prediction study (prediction model study) |
23 | The (COnsensus-based Standards for the selection of health Measurement INstruments) initiative | COSMIN RoB checklist | Patient-reported outcome measure development Content validity Structural validity Internal consistency Cross-cultural validity/ measurement invariance Reliability Measurement error Criterion validity Hypotheses testing for construct validity Responsiveness |
24 | Shea BJ et al. | AMSTAR and AMSTAR 2 | Systematic review |
25 | The Decision Support Unit (DSU) | DSU network meta-analysis (NMA) methodology checklist | Network meta-analysis |
26 | Whiting P et al. | ROBIS tool | Systematic review |
27 | Brouwers MC et al. | AGREE instrument and AGREE II instrument | Clinical practice guideline |